Philadelphia Trust Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AYX
Alteryx Inc
AYX
|
+$13.8M |
| 2 |
Enovis
ENOV
|
+$8.94M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$7.92M |
| 4 |
Palo Alto Networks
PANW
|
+$6.95M |
| 5 |
VISN
Vistance Networks Inc
VISN
|
+$6.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$9.21M |
| 2 |
Illumina
ILMN
|
+$6.74M |
| 3 |
Tower Semiconductor
TSEM
|
+$5.44M |
| 4 |
Wells Fargo
WFC
|
+$4.92M |
| 5 |
Timken Company
TKR
|
+$3.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.35% |
| 2 | Healthcare | 21.42% |
| 3 | Communication Services | 12.84% |
| 4 | Financials | 9.65% |
| 5 | Industrials | 8.64% |
Similar funds
Philadelphia Trust Company's Q4 2020 Portfolio in Review
As of Q4 2020, Philadelphia Trust Company held 225 positions worth $1.23B, up 18% from $1.04B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Philadelphia Trust Company deployed $41.3M of net new capital in Q4 2020, opening 34 new positions and adding to 65 existing holdings. Its largest new stake was Alteryx Inc: 109,195 shares worth $13.3M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was General Mills, an estimated $9.21M trimmed.
- Philadelphia Trust Company's largest Q4 2020 buy was Alteryx Inc: 109,195 shares worth $13.3M.
- Philadelphia Trust Company added most to Kyntra Bio in Q4 2020, an estimated $7.92M increase.
- Philadelphia Trust Company's biggest Q4 2020 reduction was General Mills, cutting an estimated $9.21M.
- Philadelphia Trust Company fully exited Wells Fargo in Q4 2020, selling an estimated $4.92M.
- Philadelphia Trust Company's ten largest holdings make up 33% of its $1.23B portfolio in Q4 2020.
- Philadelphia Trust Company opened 34 new positions and closed 19 in Q4 2020.
- Philadelphia Trust Company's portfolio value rose 18% quarter-over-quarter to $1.23B.
Based on Philadelphia Trust Company's 13F filing for Q4 2020, filed 8 Feb 2021.